A research filter, not a predictor — not financial advice. Grades rank growth stocks on evidence-based quality signals from end-of-day data; they are not buy/sell calls or price forecasts. Always do your own research.

Exponent, Inc. EXPO

Weak broader-coverage candidate · Exponent, Inc. functions as a global leader in scientific and engineering consulting, operating through its subsidiaries. The firm's activities are divided into two principal segme

On FrontierLab's discovery record since 2026-07-28 (3 weeks ago) — when this name first surfaced. (distinct from the snapshot date below)

Auto-graded broader coverage — sourced by an automated screen and graded on default bands, not the sector-calibrated bands the curated screener uses. A "Weak" here is NOT the same bar as a curated grade; these are auto-screened candidates for your own research, shown as of their surface date (2026-07-29), not the curated Frontier signal.

Key quality signals

Revenue growth (YoY)	7.8%
Gross margin	23.8%
Gross profits / assets	0.21
Rule of 40	27.2
Net margin	19.4%
Cash runway (months)	—
PEG	6.2
Price / sales	5.2

Quality checklist

✗ Revenue growth — 7.8% (pass ≥ 20%)
~ Gross profits / assets — 0.21 (pass ≥ 0.33)
✗ Gross margin — 23.8% (pass ≥ 60%)
✓ Cash generation
✓ Share dilution — -3%

Fundamentals — snapshot as of 2026-07-29

Stage	Established
Share issuance (YoY)	-3% · buying back shares
Moat	—
TAM	—
P/E (trailing)	30.2
EPS (trailing)	$2.15
Burn multiple	—
Gross-margin trend (pts)	-36.4
Cash / assets	0.17
Net debt / EBITDA	-0.2
Statements as of	Q1 FY2026 · filed 2026-05-08

Momentum context — a snapshot from 2026-07-29, not current

Price at surface	$65.00 (as of 2026-07-29)
52-week range	$51.91 – $81.95
% off 52-wk high	-20.7%
RSI (14)	63
Relative volume	1.1×

Risk flags

Thin gross margin — keeps little of each sales dollar (judge it against its industry).

← All broader-coverage names · Curated names → · Open the interactive screener →

Data as of 2026-07-29 (end-of-day). How grades are computed →